PL3462173T3 - Antibodies to risperidone and use thereof - Google Patents

Antibodies to risperidone and use thereof

Info

Publication number
PL3462173T3
PL3462173T3 PL18195215T PL18195215T PL3462173T3 PL 3462173 T3 PL3462173 T3 PL 3462173T3 PL 18195215 T PL18195215 T PL 18195215T PL 18195215 T PL18195215 T PL 18195215T PL 3462173 T3 PL3462173 T3 PL 3462173T3
Authority
PL
Poland
Prior art keywords
risperidone
antibodies
Prior art date
Application number
PL18195215T
Other languages
Polish (pl)
Inventor
Eric Hryhorenko
Banumathi Sankaran
Thomas R. DECORY
Theresa TUBBS
Linda COLT
Maarten VLIEGEN
Pieter Rik HASPESLAGH
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL3462173T3 publication Critical patent/PL3462173T3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/302—Schizophrenia
PL18195215T 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof PL3462173T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261691675P 2012-08-21 2012-08-21
US201361790880P 2013-03-15 2013-03-15
PCT/US2013/055803 WO2014031648A2 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof
EP13831744.1A EP2888593B1 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof
EP18195215.1A EP3462173B1 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof

Publications (1)

Publication Number Publication Date
PL3462173T3 true PL3462173T3 (en) 2021-08-16

Family

ID=50148309

Family Applications (2)

Application Number Title Priority Date Filing Date
PL18195215T PL3462173T3 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof
PL13831744T PL2888593T3 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL13831744T PL2888593T3 (en) 2012-08-21 2013-08-20 Antibodies to risperidone and use thereof

Country Status (12)

Country Link
US (2) US9664700B2 (en)
EP (3) EP2888593B1 (en)
JP (3) JP6339569B2 (en)
CN (2) CN104737017B (en)
AU (2) AU2013305887B2 (en)
CA (1) CA2882594C (en)
ES (2) ES2870004T3 (en)
HK (1) HK1212034A1 (en)
PL (2) PL3462173T3 (en)
PT (2) PT3462173T (en)
TR (1) TR201816416T4 (en)
WO (1) WO2014031648A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110003201A (en) 2012-08-21 2019-07-12 詹森药业有限公司 Paliperidone haptens
US9611332B2 (en) 2012-08-21 2017-04-04 Janssen Pharmaceutica Nv Antibodies to aripiprazole haptens and use thereof
CN110054693A (en) 2012-08-21 2019-07-26 詹森药业有限公司 The antibody and application thereof of Quetiapine haptens
US9465041B2 (en) * 2012-08-21 2016-10-11 Janssen Pharmaceutica Nv Antibodies to paliperidone and use thereof
CN108484496B (en) 2012-08-21 2022-03-22 詹森药业有限公司 Aripiprazole hapten and application thereof in immunoassay
ES2870004T3 (en) 2012-08-21 2021-10-26 Janssen Pharmaceutica Nv Risperidone antibodies and their use
US9751953B2 (en) * 2012-08-21 2017-09-05 Janssen Pharmaceutica Nv Antibodies to risperidone haptens and use thereof
EP2888287A4 (en) 2012-08-21 2016-04-20 Ortho Clinical Diagnostics Inc Antibodies to paliperidone haptens and use thereof
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
EP3333195B1 (en) 2012-08-21 2020-08-05 Janssen Pharmaceutica NV Antibodies to quetiapine and use thereof
ES2733963T3 (en) 2012-08-21 2019-12-03 Janssen Pharmaceutica Nv Antibodies against olanzapine haptens and their use
AU2013305879B2 (en) 2012-08-21 2017-10-12 Saladax Biomedical Inc. Antibodies to aripiprazole and use thereof
WO2016166415A1 (en) 2015-04-13 2016-10-20 Teknologian Tutkimuskeskus Vtt Oy Lateral flow device, assay device and kit and method for analyzing a fluid sample
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
MA44056A (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica Nv ANTI-RISPERIDONE ANTIBODIES AND THEIR USE
CN106611517B (en) * 2016-08-12 2020-04-24 简极科技有限公司 Ball tactical demonstration method and device
CN110938072A (en) * 2019-10-30 2020-03-31 杭州博拓生物科技股份有限公司 Risperidone artificial antigen and preparation method thereof
WO2022226079A1 (en) * 2021-04-20 2022-10-27 Inbios International, Inc. Neutralizing antibodies against sars-cov-2
CN114957456B (en) * 2022-05-28 2024-03-12 浙江大学医学院附属第一医院 Monoclonal antibody ZJU-A1A3 of influenza A virus hemagglutinin protein and application thereof in detection

Family Cites Families (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5576195A (en) * 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US6893625B1 (en) * 1986-10-27 2005-05-17 Royalty Pharma Finance Trust Chimeric antibody with specificity to human B cell surface antigen
EP1555529A3 (en) 1987-04-27 2008-06-04 Inverness Medical Switzerland GmbH Immunochromatographic specific binding assay device and method.
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
EP0517327B1 (en) 1991-06-07 2001-08-16 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassay with labeled hapten analogues
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
ES2153373T3 (en) 1992-05-29 2001-03-01 Lilly Co Eli DERIVATIVES OF TIENOBENZODIAZEPIN FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM.
US5642870A (en) 1992-08-05 1997-07-01 Sargis; Ike Switch stand
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
RO119224B1 (en) 1993-11-19 2004-06-30 Janssenápharmaceuticaán.V. Pharmaceutical composition for the treatment of psychotic diseases
JPH10504186A (en) 1994-06-10 1998-04-28 オクラホマ メディカル リサーチ ファウンデーション Calcium-binding recombinant antibody against protein C
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5761894A (en) 1996-09-25 1998-06-09 Magic Circle Corporation Grass striping attachment for lawn mowers
WO1998059233A1 (en) 1997-06-23 1998-12-30 Luminex Corporation Interlaced lasers for multiple fluorescence measurement
US6830731B1 (en) 1998-01-05 2004-12-14 Biosite, Inc. Immunoassay fluorometer
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US20030143233A1 (en) 1999-06-07 2003-07-31 Neorx Corporation Streptavidin expressed gene fusions and methods of use thereof
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
US7163681B2 (en) 2000-08-07 2007-01-16 Centocor, Inc. Anti-integrin antibodies, compositions, methods and uses
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
WO2003062278A1 (en) * 2002-01-25 2003-07-31 G2 Therapies Ltd MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
EP1333023B1 (en) 2002-01-31 2010-12-22 Randox Laboratories Ltd. Immunogens, antibodies and conjugates to ketamine and its metabolites
EP1485130A4 (en) 2002-02-21 2006-11-22 Univ Duke Reagents and treatment methods for autoimmune diseases
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US7214673B2 (en) 2002-03-28 2007-05-08 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
SE0201738D0 (en) 2002-06-07 2002-06-07 Aamic Ab Micro-fluid structures
EP1545618A1 (en) 2002-07-29 2005-06-29 Potomac, Pharma, LLC. Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
PT1546134E (en) 2002-08-05 2007-08-10 Lilly Co Eli Piperazine substituted aryl benzodiazepines
US7271252B2 (en) 2003-04-22 2007-09-18 Roche Diagnostics Operations, Inc. Reagents for detecting efavirenz
CN1802388B (en) 2003-05-09 2011-01-05 杜克大学 CD20-specific antibodies and methods of employing same
US7767683B2 (en) 2003-08-18 2010-08-03 H. Lundbeck A/S Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
US7863441B2 (en) 2003-09-23 2011-01-04 Fermion Oy Preparation of quetiapine
KR20140015122A (en) 2003-10-01 2014-02-06 아돌로 코포레이션 Spirocyclic heterocyclic derivatives and methods of their use
SI1675573T2 (en) * 2003-10-23 2012-08-31 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
CA2548164C (en) 2003-12-12 2013-10-08 Inverness Medical Switzerland Gmbh Assay kit for detecting analytes of interest in samples
GB0328892D0 (en) * 2003-12-12 2004-01-14 Inverness Medical Switzerland Positive signal assay for analytes
SE0400662D0 (en) 2004-03-24 2004-03-24 Aamic Ab Assay device and method
WO2005103250A1 (en) 2004-04-26 2005-11-03 Takami Matsuyama THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
SE527036C2 (en) 2004-06-02 2005-12-13 Aamic Ab Controlled flow analysis device and corresponding procedure
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
US20060235005A1 (en) 2005-04-14 2006-10-19 Oak Labs, Corp. Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
EP1874350A2 (en) * 2005-04-22 2008-01-09 Genentech, Inc. Method for treating dementia or alzheimer's disease with a cd20 antibody
US20080214808A1 (en) 2005-04-25 2008-09-04 Thomas Frederik Ernestine Spittaels Preparation of Aseptic 3-[2-[4-((6-Fluoro-1,2-Benzisoxazol-3-Yl)-1-Piperidinyl]-6,7,8,9-Tetrahydro-9-Hydroxy-2-Methyl-4H-Pyrido[1,2-a]Pyrimidin-4-One Palmitate Ester
SE529254C2 (en) 2005-06-17 2007-06-12 Aamic Ab Optical test system
SE528233C2 (en) 2005-06-20 2006-09-26 Aamic Ab Fluid handling device for handling fluid to be assayed, comprises absorbing zone(s) in fluid contact with second end of first passage and comprising projections perpendicular to substrate surface and capable of generating capillary flow
SE529711C2 (en) 2006-03-22 2007-11-06 Aamic Ab Fluorescence Readers
US8975374B2 (en) * 2006-10-20 2015-03-10 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
WO2008047925A1 (en) 2006-10-20 2008-04-24 Forerunner Pharma Research Co., Ltd. Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
CN101589059A (en) * 2006-10-20 2009-11-25 株式会社未来创药研究所 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
CN101636182B (en) * 2006-10-25 2013-01-16 雷蒙特亚特特拉维夫大学有限公司 Novel psychotropic agents having glutamate NMDA activity
US20080138842A1 (en) 2006-12-11 2008-06-12 Hans Boehringer Indirect lateral flow sandwich assay
EP2103628A4 (en) * 2006-12-14 2012-02-22 Forerunner Pharma Res Co Ltd Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
JP5450092B2 (en) 2006-12-29 2014-03-26 アボット・ラボラトリーズ Diagnostic tests for detection of molecules or drugs in whole blood
CN101600716A (en) 2007-01-08 2009-12-09 阿特维斯集团公司 Be used to prepare improving one's methods of 9-hydroxyl-3-(2-chloroethyl)-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one hydrochloride
CN101245065B (en) 2007-02-14 2010-05-19 江苏恩华药业股份有限公司 Method for producing benzo isoxazole derivative and its intermediate
CA2699062A1 (en) 2007-09-27 2009-04-02 Novartis Ag Drug monitoring assay
WO2010104747A2 (en) 2009-03-10 2010-09-16 Baylor Research Institute Antigen presenting cell targeted vaccines
EA028427B1 (en) 2008-07-21 2017-11-30 Пробиодруг Аг ANTIBODY BINDING TO Aβ-PEPTIDES OR OR VARIANTS THEREOF, COMPOSITION COMPRISING THIS ANTIBODY AND USE THEREOF
CN102170874A (en) 2008-08-06 2011-08-31 高思福斯中心（控股）有限公司 Compositions and methods for treating psychiatric disorders
WO2010033270A1 (en) 2008-09-17 2010-03-25 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
CN104086565A (en) 2008-10-14 2014-10-08 阿斯利康(瑞典)有限公司 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
WO2010096117A2 (en) 2008-10-29 2010-08-26 Janssen Pharmaceutica Nv Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
US8480333B2 (en) 2008-12-26 2013-07-09 Steven Edward DeMay Frame rail assemblies and interlocking frame rail systems
EP2389169A1 (en) 2009-01-26 2011-11-30 Egalet A/S Controlled release formulations with continuous efficacy
CA2937222C (en) 2009-06-25 2019-06-04 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds
WO2011004028A2 (en) * 2009-07-10 2011-01-13 Innate Pharma Tlr3 binding agents
SG177761A1 (en) 2009-07-31 2012-03-29 Ascendis Pharma As Biodegradable polyethylene glycol based water-insoluble hydrogels
CA2771436A1 (en) 2009-08-17 2011-02-24 Forerunner Pharma Research Co., Ltd. Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
WO2011042450A1 (en) 2009-10-06 2011-04-14 Ascendis Pharma As Carrier linked paliperidone prodrugs
EP2343296A1 (en) 2009-12-01 2011-07-13 Chemo Ibérica, S.A. A process for the purification of paliperidone
CN104586859B (en) 2009-12-31 2017-12-05 凯姆制药公司 The amino acid conjugate of Quetiapine, its preparation and application
EP2544536B1 (en) 2010-03-11 2018-12-12 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8114621B2 (en) 2010-03-12 2012-02-14 Saladax Biomedical Inc. Lenalidomide and thalidomide immunoassays
US8088594B2 (en) * 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
WO2011159537A2 (en) 2010-06-15 2011-12-22 The Regents Of The University Of California Method and device for analyte detection
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
CA2802733C (en) 2010-06-24 2017-11-21 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
WO2012003418A2 (en) 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine d2 receptors
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
UA114883C2 (en) * 2010-08-20 2017-08-28 Новартіс Аг Antibodies for epidermal growth factor receptor 3 (her3)
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
AU2012296949B2 (en) 2011-08-12 2016-09-15 Ascendis Pharma A/S High-loading water-soluble carrier-linked prodrugs
AU2012296950B2 (en) 2011-08-12 2016-09-22 Ascendis Pharma A/S Polymeric hyperbranched carrier-linked prodrugs
CA2858787C (en) 2011-12-15 2017-11-21 Alkermes Pharma Ireland Limited Prodrugs of tertiary amine compounds
WO2014028800A1 (en) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Substituted pyrazoles as n-type calcium channel blockers
ES2870004T3 (en) 2012-08-21 2021-10-26 Janssen Pharmaceutica Nv Risperidone antibodies and their use
EP3333195B1 (en) 2012-08-21 2020-08-05 Janssen Pharmaceutica NV Antibodies to quetiapine and use thereof
ES2733963T3 (en) 2012-08-21 2019-12-03 Janssen Pharmaceutica Nv Antibodies against olanzapine haptens and their use
EP2888287A4 (en) 2012-08-21 2016-04-20 Ortho Clinical Diagnostics Inc Antibodies to paliperidone haptens and use thereof
US9465041B2 (en) 2012-08-21 2016-10-11 Janssen Pharmaceutica Nv Antibodies to paliperidone and use thereof
US9611332B2 (en) 2012-08-21 2017-04-04 Janssen Pharmaceutica Nv Antibodies to aripiprazole haptens and use thereof
CN110003201A (en) 2012-08-21 2019-07-12 詹森药业有限公司 Paliperidone haptens
US9751953B2 (en) * 2012-08-21 2017-09-05 Janssen Pharmaceutica Nv Antibodies to risperidone haptens and use thereof
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
AU2013305936B2 (en) * 2012-08-21 2017-08-03 Saladax Biomedical Inc. Haptens of risperidone and paliperidone
CN108484496B (en) 2012-08-21 2022-03-22 詹森药业有限公司 Aripiprazole hapten and application thereof in immunoassay
CN110054693A (en) 2012-08-21 2019-07-26 詹森药业有限公司 The antibody and application thereof of Quetiapine haptens
ES2645433T3 (en) 2012-08-21 2017-12-05 Janssen Pharmaceutica, N.V. Quepiapine haptenos for use in immunoassays
AU2013305879B2 (en) 2012-08-21 2017-10-12 Saladax Biomedical Inc. Antibodies to aripiprazole and use thereof
JP6171014B2 (en) 2012-08-21 2017-07-26 ヤンセン ファーマシューティカ エヌ．ベー． Olanzapine hapten
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
MA44056A (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica Nv ANTI-RISPERIDONE ANTIBODIES AND THEIR USE

Also Published As

Publication number Publication date
CA2882594A1 (en) 2014-02-27
JP6339569B2 (en) 2018-06-06
EP3462173B1 (en) 2021-03-31
AU2013305887A1 (en) 2015-03-05
JP2020143059A (en) 2020-09-10
TR201816416T4 (en) 2018-11-21
WO2014031648A2 (en) 2014-02-27
HK1212034A1 (en) 2016-06-03
US9664700B2 (en) 2017-05-30
EP2888593B1 (en) 2018-09-19
EP3933406A2 (en) 2022-01-05
US20170299618A1 (en) 2017-10-19
CN104737017B (en) 2017-03-08
ES2870004T3 (en) 2021-10-26
EP2888593A4 (en) 2016-07-20
PL2888593T3 (en) 2019-02-28
CN107043424A (en) 2017-08-15
US20140057302A1 (en) 2014-02-27
CN104737017A (en) 2015-06-24
WO2014031648A3 (en) 2014-05-01
ES2691092T3 (en) 2018-11-23
US10690686B2 (en) 2020-06-23
JP2018127456A (en) 2018-08-16
PT2888593T (en) 2018-12-12
PT3462173T (en) 2021-04-28
EP2888593A2 (en) 2015-07-01
CN107043424B (en) 2021-03-16
EP3462173A1 (en) 2019-04-03
AU2018203561B2 (en) 2020-05-21
JP2015527367A (en) 2015-09-17
AU2013305887B2 (en) 2018-02-22
CA2882594C (en) 2019-07-16
EP3933406A3 (en) 2022-04-20
AU2018203561A1 (en) 2018-06-07

Similar Documents

Publication Publication Date Title
HK1212034A1 (en) Antibodies to risperidone and use thereof
HK1255219A1 (en) Antibodies to quetiapine and use thereof
HK1211957A1 (en) Antibodies to risperidone haptens and use thereof
HK1207092A1 (en) Anti-hla-b27 antibodies and uses thereof -hla-b27
HRP20190358T1 (en) Anti-asic1 antibodies and uses thereof
HK1211958A1 (en) Antibodies to paliperidone and use thereof
SG11201407099WA (en) Anti-pcsk9 antibodies and use thereof
HK1260330A1 (en) Antibodies to aripiprazole and use thereof
HK1212033A1 (en) Antibodies to olanzapine and use thereof
HK1211956A1 (en) Antibodies to paliperidone haptens and use thereof
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
IL238366A0 (en) Antibodies to interleukin-6 and uses thereof
HK1209432A1 (en) Anti-jagged antibodies and methods of use
GB201208372D0 (en) Antibodies and uses thereof